Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA.

We have observed marked interindividual differences in release rates of tissue-type plasminogen activator (t-PA) among healthy subjects. The objective of the current study was to test the hypothesis that there is an association between a genetic variation at the t-PA locus and the in vivo release rate of t-PA. Fifty-one healthy males were studied at rest in the morning and 27 of these were also subjected to a mental stress test. Net release rates of total t-PA across the forearm vascular bed were calculated as the product of the venoarterial concentration gradient and forearm plasma flow. Zygosity for an Alu-repeat polymorphism in intron 8 of the t-PA gene was determined by a polymerase chain reaction. Basal t-PA release rates differed markedly by genotype (ANOVA, P<0.05); subjects homozygous for the insertion had a significantly higher release rate (mean 10.9 ng. min-1. L-1, n=19) than both heterozygotes (4.5 ng. min-1. L-1, n=26) and subjects homozygous for the deletion (0.9 ng. min-1. L-1, n=6). After 2 minutes of mental stress release rates had increased approximately 2-fold in all groups. Arterial and venous plasma levels of t-PA were unrelated to genotype. In conclusion, the current results provide the first evidence of an association between a common genetic variation at the t-PA locus and interindividual differences in net release rates of t-PA in vivo. The relationship is not reflected by circulating steady-state plasma levels and can thus not be disclosed by conventional venous plasma sampling.

[1]  C. Jern,et al.  Enhanced levels of tissue-type plasminogen activator in borderline hypertension. , 1995, Hypertension.

[2]  SverkerJern,et al.  Endothelium-Dependent Vasodilation and Tissue-Type Plasminogen Activator Release in Borderline Hypertension , 1997 .

[3]  M. Rånby,et al.  Immunoreactivity of Tissue Plasminogen Activator and of Its Inhibitor Complexes , 1989, Thrombosis and Haemostasis.

[4]  J. Emeis.  The Control of tPA and PAI-1 Secretion from the Vessel Wall , 1995 .

[5]  C. Jem,et al.  Application of the perfused-forearm model to study release mechanisms of tissue-type plasminogen activator in man , 1994 .

[6]  C. Jern,et al.  Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. , 1998, Blood.

[7]  P. de Knijff,et al.  Alu-repeat Polymorphism in the Tissue-Type Plasminogen Activator (tPA) Gene Does not Affect Basal Endothelial tPA Synthesis , 1995, Thrombosis and Haemostasis.

[8]  T. Kooistra,et al.  Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. , 1995, Blood.

[9]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[10]  N. Reichek.  Role of nitroglycerin in effort angina. , 1983, The American journal of medicine.

[11]  S. Thorsen,et al.  A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. , 2009, Scandinavian journal of haematology.

[12]  V. Rasi,et al.  Familial clustering of defective release of t‐PA , 1991, British journal of haematology.

[13]  A. Castelnuovo,et al.  Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI) , 1996 .

[14]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[15]  C. Jern,et al.  Release of Tissue-Type Plasminogen Activator in Response to Muscarinic Receptor Stimulation in Human Forearm , 1994, Thrombosis and Haemostasis.

[16]  W. Chandler,et al.  Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. , 1997, Circulation.

[17]  C. Kluft.  Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAT-1): Conditions and therapeutic targets , 1994 .

[18]  S. Humphries,et al.  Variation in the Promoter Region of the β Fibrinogen Gene Is Associated with Plasma Fibrinogen Levels in Smokers and Non-Smokers , 1991, Thrombosis and Haemostasis.

[19]  S. Pizzo,et al.  Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. , 1983, The American journal of medicine.

[20]  C. Jern,et al.  In Vivo Release of Tissue-Type Plasminogen Activator across the Human Forearm during Mental Stress , 1994, Thrombosis and Haemostasis.

[21]  G. Dahlén,et al.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.

[22]  S. Diamond,et al.  Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress , 1990, Journal of cellular physiology.

[23]  C. Jern,et al.  Short-term reproducibility of a mental arithmetic stress test. , 1991, Clinical science.

[24]  J. Emeis,et al.  An Endothelial Storage Granule for Tissue-Type Plasminogen Activator , 1997, The Journal of cell biology.

[25]  F. Green,et al.  Genetic determinants of arterial thrombosis. , 1994, Bailliere's clinical haematology.

[26]  P. Ridker,et al.  Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Henney,et al.  Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  J. Emeis.  Regulation of the Acute Release of Tissue‐type Plasminogen Activator from the Endothelium by Coagulation Activation Products , 1992, Annals of the New York Academy of Sciences.

[29]  A. Hofman,et al.  Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. , 1997, Circulation.

[30]  C. Jern,et al.  Changes of Plasma Coagulation and Fibrinolysis in Response to Mental Stress , 1989, Thrombosis and Haemostasis.

[31]  T. Meade,et al.  A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  W. Chandler,et al.  The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. , 1995, Circulation.

[33]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[34]  C. Jern,et al.  An Experimental Multiple-Organ Model for the Study of Regional Net Release/Uptake Rates of Tissue-type Plasminogen Activator in the Intact Pig , 1997, Thrombosis and Haemostasis.

[35]  R. J. Whitney,et al.  The measurement of volume changes in human limbs , 1953, The Journal of physiology.

[36]  C. Jern,et al.  Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[37]  J. Fettich,et al.  lncrease of Tissue Plasminogen Activator in Limbs During Venous Occlusion : A Simple Haemodynamic Model , 1990, Thrombosis and Haemostasis.